» Articles » PMID: 21199446

The Upside of APP at Synapses

Overview
Specialties Neurology
Pharmacology
Date 2011 Jan 5
PMID 21199446
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

The memory dysfunctions that characterize Alzheimer's disease (AD) are strongly correlated with synapse loss. The amyloid precursor protein (APP) and its cleavage product Aβ play central roles in synapse and memory loss, and thus are strongly implicated in the pathogenesis of AD. Numerous in vitro and transgenic AD mouse model studies have shown that overexpression of APP leads to Aβ accumulation, which causes decreased synaptic activity and dendritic spine density. However, the normal synaptic function of APP itself is not fully understood. Several recent studies have found that full-length APP promotes synaptic activity, synapse formation, and dendritic spine formation. These findings cast APP as a potential key player in learning and memory. It is of interest that the synaptic functions of full-length APP are opposite to the effects associated with pathological Aβ accumulation. In this review, we will summarize the normal functions of APP at synapses and spines along with other known functions of APP, including its role in cell motility, neuronal migration, and neurite outgrowth. These studies shed light on the physiological actions of APP, independent of Aβ effects, and thus lead to a better understanding of the synaptic dysfunctions associated with AD.

Citing Articles

Insulin resistance in Alzheimer's disease: signalling mechanisms and therapeutics strategies.

Dahiya M, Yadav M, Goyal C, Kumar A Inflammopharmacology. 2025; .

PMID: 40064805 DOI: 10.1007/s10787-025-01704-2.


Decoding the Role of Neurotrophins in Glycogen Synthase Kinase 3-Beta Regulation in Alzheimer's Disease.

Rahmatkar S, Singh D Mol Neurobiol. 2025; .

PMID: 40014269 DOI: 10.1007/s12035-025-04776-x.


Pathways linking microbiota-gut-brain axis with neuroinflammatory mechanisms in Alzheimer's pathophysiology.

Hochuli N, Kadyan S, Park G, Patoine C, Nagpal R Microbiome Res Rep. 2024; 3(1):9.

PMID: 38455083 PMC: 10917618. DOI: 10.20517/mrr.2023.39.


Interactions of amyloidogenic proteins with mitochondrial protein import machinery in aging-related neurodegenerative diseases.

Reed A, Mitchell W, Alexandrescu A, Alder N Front Physiol. 2023; 14:1263420.

PMID: 38028797 PMC: 10652799. DOI: 10.3389/fphys.2023.1263420.


Coupling of Alzheimer's Disease Genetic Risk Factors with Viral Susceptibility and Inflammation.

Cao C, Fu G, Xu R, Li N Aging Dis. 2023; 15(5):2028-2050.

PMID: 37962454 PMC: 11346407. DOI: 10.14336/AD.2023.1017.


References
1.
Hoe H, Tran T, Matsuoka Y, Howell B, Rebeck G . DAB1 and Reelin effects on amyloid precursor protein and ApoE receptor 2 trafficking and processing. J Biol Chem. 2006; 281(46):35176-85. DOI: 10.1074/jbc.M602162200. View

2.
Herard A, Besret L, Dubois A, Dauguet J, Delzescaux T, Hantraye P . siRNA targeted against amyloid precursor protein impairs synaptic activity in vivo. Neurobiol Aging. 2005; 27(12):1740-50. DOI: 10.1016/j.neurobiolaging.2005.10.020. View

3.
Ma Q, Futagawa T, Yang W, Jiang X, Zeng L, Takeda Y . A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis. Nat Cell Biol. 2008; 10(3):283-94. DOI: 10.1038/ncb1690. View

4.
Carmignoto G, Vicini S . Activity-dependent decrease in NMDA receptor responses during development of the visual cortex. Science. 1992; 258(5084):1007-11. DOI: 10.1126/science.1279803. View

5.
Herms J, Anliker B, Heber S, Ring S, Fuhrmann M, Kretzschmar H . Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members. EMBO J. 2004; 23(20):4106-15. PMC: 524337. DOI: 10.1038/sj.emboj.7600390. View